Journal Article

DZNE-2024-01411

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Analysis of the senescence-associated cell surfaceome reveals potential senotherapeutic targets.

Deng, Y. (First author)DZNE* ; Liu, T.DZNE* ; Scifo, E.DZNE* ; Li, T. ; Xie, K.DZNE* ; Taschler, B.Extern* ; Morsy, S.DZNE* ; Schaaf, K.DZNE* ; Ehninger, A. ; Bano, D.DZNE* ; Ehninger, D. (Last author)DZNE*

2024
Wiley-Blackwell Oxford [u.a.]

This record in other databases:    

Please use a persistent id in citations: doi:10.1111/acel.14312

Abstract: The accumulation of senescent cells is thought to play a crucial role in aging-associated physiological decline and the pathogenesis of various age-related pathologies. Targeting senescence-associated cell surface molecules through immunotherapy emerges as a promising avenue for the selective removal of these cells. Despite its potential, a thorough characterization of senescence-specific surface proteins remains to be achieved. Our study addresses this gap by conducting an extensive analysis of the cell surface proteome, or 'surfaceome', in senescent cells, spanning various senescence induction regimes and encompassing both murine and human cell types. Utilizing quantitative mass spectrometry, we investigated enriched cell surface proteins across eight distinct models of senescence. Our results uncover significant changes in surfaceome expression profiles during senescence, highlighting extensive modifications in cell mechanics and extracellular matrix remodeling. Our research also reveals substantive heterogeneity of senescence, predominantly influenced by cell type and senescence inducer. A key discovery of our study is the identification of four unique cell surface proteins with extracellular epitopes. These proteins are expressed in senescent cells, absent or present at low levels in their proliferating counterparts, and notably upregulated in tissues from aged mice and an Alzheimer's disease mouse model. These proteins stand out as promising candidates for senotherapeutic targeting, offering potential pathways for the detection and strategic targeting of senescent cell populations in aging and age-related diseases.

Keyword(s): Cellular Senescence: drug effects (MeSH) ; Animals (MeSH) ; Humans (MeSH) ; Mice (MeSH) ; Senotherapeutics: pharmacology (MeSH) ; Aging: metabolism (MeSH) ; Membrane Proteins: metabolism (MeSH) ; aging ; cell surface proteins ; cellular senescence ; mass spectrometry ; senotherapeutics ; Senotherapeutics ; Membrane Proteins

---

Contributing Institute(s):

1. Translational Biogerontology (AG Ehninger)
2. Aging and Neurodegeneration (AG Bano)

Research Program(s):

1. 352 - Disease Mechanisms (POF4-352) (POF4-352)
2. 351 - Brain Function (POF4-351) (POF4-351)

Appears in the scientific report 2024

---

Database coverage:
; ; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---